Organigram Secures C$65.2M BAT Private Placement for Sanity Acquisition
Organigram Global confirmed a C$65.2 million private placement from British American Tobacco’s subsidiary, comprising 14.03 million shares at C$3.00 and top-up rights for 9.90 million shares at C$2.335854 each. Proceeds will fund the cash portion of the €113.4 million Sanity Group acquisition and cover transaction costs.
1. Private Placement Details
Organigram Global’s subsidiary of British American Tobacco has agreed to subscribe for 14,027,074 shares at C$3.00 and exercise top-up rights for 9,897,356 shares at C$2.335854 each, generating C$65.2 million in gross proceeds to strengthen its capital structure.
2. Sanity Acquisition Funding
Proceeds will be allocated to the cash portion of the €113.4 million upfront consideration payable to Sanity Group GmbH, covering related transaction expenses and bolstering working capital for the combined operations.
3. Financial Clarity and Strategic Alignment
The confirmed investment reduces funding uncertainty for the Sanity deal, reinforces backing from British American Tobacco and underlines Organigram’s strategy to build a global pure-play cannabis platform with deeper European market exposure.
4. Technical Indicators and Market Sentiment
Shares are trading above the 20-day simple moving average but below the 100-day average, with an RSI of 41.29 and a bearish MACD, reflecting mixed momentum and cautious investor sentiment ahead of upcoming catalysts.